Videos

Andrew D. Zelenetz, Md, PhD, medical director of quality informatics at Memorial Sloan Kettering Cancer Center, discusses what patients often do not tell their doctors but discuss with their nurses.

Kilian Salerno, director of Breast Radiation and Soft Tissue/Melanoma Radiation, Roswell Park Cancer Center, discusses assessing cancer risk.

E. David Crawford, MD, professor of radiation oncology University of Colorado Denver, discusses the potential side effects of frequently used prostate cancer treatments.

Oliver Sartor, MD, Medical Director Tulane Cancer Center, discusses some of the most common questions patients have when starting treatment with Radium-223, and how nurses can play a role in patient education.

​Sumanta K. Pal, MD, City of Hope Cancer Center, discusses the role that nurses will play in the shifting paradigm of cancer treatment.

​David Steensma, MD, Dana-Farber Cancer Institute, discusses treatment options for myelodysplastic syndromes. 

Jae Park, MD, hematologist-oncologist, Memorial Sloan Kettering Cancer Center, talks about CAR T-cell activation therapy, which is currently in clinical trials for patients with acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), and non-Hodgkin lymphoma.

​Sarah B. Goldberg, MD, MPH, assistant professor of medicine at Yale Cancer Center, discusses the side effects of immunotherapy on patients with non-small cell lung cancer.

Debu Tripathy, MD, chair of the Department of Breast Medical Oncology at University of Texas MD Anderson Cancer Center, discusses genetic risk for breast cancer, the strongest factor in determining if an individual will develop the disease.

Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.

Kevin Hughes, MD, breast surgeon at Massachusetts General Hospital, discusses misconceptions regarding dense breast tissue and risk for breast cancer.

Anees B. Chagpar, MD, MSc, MA, MPH, discusses the role of nurses in the decision making process for breast cancer care.

Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).

Amelie Harle, an oncologist at Christie Hospital in Manchester, United Kingdom, discusses the possibility of using aprepitant (Emend) to treat cough in patients with lung cancer.

Kavita Dharmarajan, MD, MSc, assistant professor of radiation oncology and palliative medicine at the Icahn School of Medicine at Mount Sinai Hospital, discusses how patients benefit when healthcare providers look at the “whole picture” in advanced stage cancer treatment. 

Carolyn Lefkowits, MD, MPH, MS, assistant professor, University of Colorado Denver, discusses concerns women with gynecologic cancer have regarding their prognosis.

Kathrin Milbury, PhD, assistant professor of Integrative Medicine Research at The University of Texas MD Anderson Cancer Center, discusses the importance of spouse and caregiver self care when tending to someone with lung cancer.

Areej El-Jawahri, MD, an oncologist at Massachusetts General Hospital, discusses how patients with cancer do not often have a full understanding of the terms and processes doctors describe during treatment.

Joseph Ravenell, MD, MS, from NYU Langone Medical Center, discusses access to screening among black men.

Kathy Jo Gutgsell, RN, MT-BC, music therapist at University Hospitals Seidman Cancer Center talks about how music can help patients with cancer.

Rajni Kannan, BS, MS, RN, ANP-BC, discusses some risk factors for melanoma that may not be widely known.

Kathleen M. Madden, MSN, FNP-BC, AOCNP®, provides an overview of treatment of melanoma with new targeted therapies.

Women under 40 who find a suspicious lump in their breast often have their cancer fears dismissed and are told “you are too young for breast cancer,” according to Megan McCann, associate director of programs at the Young Survival Coalition. Here, she discusses breaking down that misconception that younger women can’t get breast cancer.

Samantha Ganey Aquino, MSN, AGPCNP-BC, discusses pain management for patients with cancer.

Jan Lewin, PhD, section chief of Speech Pathology and Audiology at The University of Texas MD Anderson Cancer Center, discusses the two different types of lymphedema and the importance of getting treated. 

While eating during treatment for head and neck cancer may be uncomfortable, Giselle Carnaby, PhD, MPH, CCC-SLP, ASHA fellow and professor at University of Central Florida College of Health and Public Affairs, emphasizes that it is vitally important.

Maria Cabanillas, MD, explains that for people who are newly diagnosed with thyroid cancer, it is imperative that they know all the details about their cancer before heading into surgery. 

After leading a study that patients with acute myeloid leukemia who receive induction chemotherapy are quite distressed, Tom LeBlanc, hematologic malignancy specialist at Duke Cancer Institute, decided more palliative care should be offered alongside treatment for the disease. 

Robert Andtbacka, MD, from University of Utah School of Medicine, discusses the management of side effects from T-VEC.

Mario E. Lacouture, MD, discusses the psychosocial impact of dermatologic adverse events from novel therapies in melanoma.